Regenerative medicine partnerships get attention of Japanese drugmakers
21 December 2015
Takeda Pharmaceuticals and other Japanese drugmakers are latching on to regenerative medicine and stem cell research as a future growth market and are quickly developing partnerships and acquiring overseas ventures to tap the market.
University of California commits $250M for a new tech venture fund for biotech, more
21 December 2015
The University of California is committing $250 million to back a venture fund that will be led by Silicon Valley entrepreneur Vivek Ranadivé, who will take the lead on investing in a slate of university spinouts involved in biotech and more.
Drug costs soar as China tops world ranking in cancer
21 December 2015
As World Health Organization figures show China rising to the top of the list of countries with the most cancer cases, its people are facing increasing problems in trying to find ways to pay for their treatments. Healthcare costs are soaring in the nation despite the government's efforts to force drug prices lower.
If you can't beat 'em, join 'em; looking for immuno-onc boost
18 December 2015
Last week, Threshold Pharmaceuticals Inc. announced the failure of two phase III evofosfamide trials, one in pancreatic cancer and another in soft tissue sarcoma, but Barry Selick, CEO of the South San Francisco-based company, gave investors some hope that the drug might work in combination with immune checkpoint inhibitors.
A Universal Virus Test Could Be Just What the Doctor Ordered
18 December 2015
Lipkin and six researchers developed a shoebox-size add-on to a genetic sequencer they say can accurately identify more than 1,000 viruses known to affect vertebrates, so doctors don’t have to test for infections one at a time.
18 December 2015
With more than 85 million Americans living with some type of cardiovascular disease, including more than six million adults who have had a stroke, chances are that you or someone you know would stand to benefit from new medicines that help prevent and treat these illnesses.
Analyst: Use of tech to streamline clinical trials 'still early in its adoption cycle'
17 December 2015
In recent years, technology has gone from being a novelty in clinical trials to the cornerstone of the research process. But with sponsors and CROs alike looking to IT to make studies more efficient, the expectation among observers is that the incorporation of tech into trials is just getting started.
Pharma brands need the human touch, and MS marketing offers some ideas
17 December 2015
What's the best path forward for healthcare brands? It starts with making a difference and serving the people they're working to connect with, according to Digitas Health executive director Graham Mills--and that's something he says marketers in the multiple sclerosis space already do exceptionally well.
Developer of simple, procedural solution to sleep apnea finds commercialization partner
17 December 2015
Irvine, CA's Alphaeon gained exclusive worldwide commercialization rights to Zelegent's in-office procedure to reduce snoring, as devicemakers scramble to develop new methods to combat obstructive sleep apnea.
Report suggests that to grow, India's industry must sync its standards to the West
17 December 2015
Scores of Indian drugmakers, including India's largest, are having to make plant improvements and change their processes after FDA regulators cited their plants for all sorts of shortcomings. And that is likely to keep happening if the Indian pharma industry, with help from the government, doesn't make some serious improvements, warns a top business group in the country.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024